CSIMarket Company Name, Ticker, Customers, else..
 
Akili Inc   (NASDAQ: AKLI)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 79
 Employees 114
 Revenues (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) -49
 Cash Flow (TTM) (Millions $) -25
 Capital Exp. (TTM) (Millions $) 0

Business Description


Akili Inc is a digital medicine company that is focused on developing clinically-validated prescription treatments using video game technology. They create interactive entertainment experiences designed to target specific cognitive systems in the brain. These digital therapies are aimed at addressing various medical conditions and improving neurological conditions. Akili's products have been successfully used in clinical trials and show potential in treating conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The company is at the forefront of the emerging field of digital therapeutics, utilizing innovative technology to provide novel treatment options.


   Company Address: 71 Commercial Street Boston 2109 MA
   Company Phone Number: 313-8853   Stock Exchange / Ticker: NASDAQ AKLI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
LFST        6.09% 
PIII   -5.14%    
DFTX   -11.13%    
TDOC        2.05% 
• View Complete Report
   



Business Update

Empowering Adults with ADHD The Game-Changer in Mental Health Treatment

Published Tue, Jun 18 2024 9:08 PM UTC

The Future of ADHD Treatment: Akili Announces FDA Clearance for Over-the-Counter Digital TherapyIn a groundbreaking development for the field of mental health, Akili Inc. has received FDA authorization for the first over-the-counter digital treatment for adults with attention-deficit/hyperactivity disorder (ADHD). The clearance of EndeavorOTC (AKL-T01) marks a significant mi...
Business Update

Akili Inc. Initiates Evaluation of Strategic Alternatives to Enhance Shareholder Value

Published Tue, May 14 2024 8:47 PM UTC

Boston-based digital medicine company, Akili Inc. (Nasdaq: AKLI), released its financial results for the first quarter ended March 31, 2024, along with an update on its business progress. In a recent announcement made in late April 2024, the company s board of directors has initiated a comprehensive evaluation of potential strategic alternatives to enhance shareholder value....
Business Update

Akili Announces Strategic Amendments with Shionogi and Shows Promise with Sequential Revenue Growth

Published Tue, Apr 30 2024 12:47 PM UTC

Leading digital medicine company, Akili Inc., recently announced several corporate updates, underscoring its evolving distribution agreement with pharmaceutical giant Shionogi & Co., Ltd. This amendment sees the cancellation of a significant long-term debt obligation and additional payments for the Japanese version of Akili s flagship product, AKL-T01. Alongside these develo...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 6.05
Working Capital Ratio 6.23
Leverage Ratio (MRQ) 0.24
Total Debt to Equity 0.18
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.88 $
Revenues (TTM) 0.02 $
Cash Flow (TTM) -
Cash 0.8 $
Book Value 0.64 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 17,088
Net Income per Employee (TTM) -425,833
Receivable Turnover Ratio (TTM) 8.03
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.02

Profitability Ratios Current
Gross Margin (MRQ) 54.83 %
Operating Margin (MRQ) -2836.81 %
Net Margin (MRQ) -2549.09 %
Net Cash Flow Margin (MRQ) -3162.92 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.